M. McDonnell (Oranmore (Co Galway), Ireland), J. Altenburg (Amsterdam (NH), Netherlands)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
The journey to bronchiectasis diagnosis and care: an EMBARC/ELF patient survey A. Spinou (London, United Kingdom), M. Almagro (Sheffield, United Kingdom), B. Harris (Sheffield, United Kingdom), J. Boyd (Sheffield, United Kingdom), T. Berg (Sheffield, United Kingdom), B. Herrero (Zaragosa, Spain), A. Posthumous (Sheffield, United Kingdom), S. Aliberti (Milan, Italy), B. Crossley (Sheffield, United Kingdom), T. Ruddy (Sheffield, United Kingdom), J. Chalmers (Dundee, United Kingdom), M. Shteinberg (Haifa, Israel)
|   |
Translation and validation of the Quality-of-Life Bronchiectasis questionnaire in Swedish, and correlation with clinical outcomes. P. Ghosh (Stockholm, Sweden), I. Gerhardson (Stockholm, Sweden), R. Middelveld (Stockholm, Sweden), A. Ek (Stockholm, Sweden), A. Panagiotou (Stockholm, Sweden), S. Dahlén (Stockholm, Sweden), B. Dahlén (Stockholm, Sweden), A. Bossios (Stockholm, Sweden)
|   |
Nebulized saline treatment in patients with concomitant asthma and bronchiectasis E. AVALOS PEREZ-URRIA (Madrid , Spain), C. Cisneros (Madrid , Spain), R. Girón (Madrid , Spain), A. Sanchez Azofra (Madrid , Spain), C. Marcos (Madrid , Spain), T. Alonso (Madrid , Spain), G. Iturricastillo (Madrid , Spain), A. Martinez Meca (Madrid , Spain), J. Ancochea (Madrid , Spain)
|   |
Vestibular function in adult patients with primary ciliary dyskinesia N. Winthereik (Copenhagen, Denmark), M. Alanin (Copenhagen, Denmark), K. Nielsen (Copenhagen, Denmark), C. Von Buchwald (Copenhagen, Denmark), S. Bloch (Copenhagen, Denmark)
|   |
Bronchiectasis severity assessment tools to predict clinical outcomes in the Indian Bronchiectasis Registry R. Dhar (Kolkata, India), S. Singh (JaipurJaipur, India), D. Talwar (Metro centre for Respiratory Diseases, India), M. Mohan (Narayana Hrudayalaya, India), S. Tripathi (Uttar Pradesh, India), R. Swarnakar (Nagpur, India), S. Trivedi (Chhattisgarh, India), S. Rajagopala (Tamil Nadu, India), G. D'Souza (Karnataka, India), A. Padmanabhan (Kerala, India), A. Baburao (Karnataka, India), M. Crichton (Dundee, United Kingdom), J. Chalmers (Dundee, United Kingdom), S. Limaye (Pune, India), S. Salvi (Pune, India)
|   |
FACED and BSI concordance in predicting bronchiectatsis severity H. Zaibi (Tunis, Tunisia), A. Jarrar (Tunis, Tunisia), E. Ben Jemia (Tunis, Tunisia), H. Ouertani (Tunis, Tunisia), J. Ben Amar (Tunis, Tunisia), H. Aouina (Tunis, Tunisia)
|   |
Contribution of BSI and FACED scores in prediction of bronchiectasis mortality H. Zaibi (Tunis, Tunisia), A. Jarrar (Tunis, Tunisia), E. Ben Jemia (Tunis, Tunisia), A. Naaroura (Tunis, Tunisia), J. Ben Amar (Tunis, Tunisia), H. Aouina (Tunis, Tunisia)
|   |
Bronchiectasis exacerbations risk prediction using severity scales BSI and FACED H. Zaibi (Tunis, Tunisia), A. Jarrar (Tunis, Tunisia), E. Ben Jemia (Tunis, Tunisia), H. Ouertani (Tunis, Tunisia), J. Ben Amar (Tunis, Tunisia), H. Aouina (Tunis, Tunisia)
|   |
Elevated blood eosinophils in bronchiectasis: A distinct phenotype? N. Boubaker (Ariana, Tunisia), S. Louhaichi (Ariana, Tunisia), I. Khalfallah (Ariana, Tunisia), M. Ferchichi (Ariana, Tunisia), S. Belkhir (Ariana, Tunisia), J. Ammar (Ariana, Tunisia), B. Hamdi (Ariana, Tunisia), A. Hamzaoui (Ariana, Tunisia)
|   |
Analysis of the Effect of pneumococcal vaccination in patients with COPD in combination with bronchiectasis E. Blinova (Chelyabinsk (Chelyabinsk Oblast), Russian Federation), G. Ignatova (Chelyabinsk (Chelyabinsk Oblast), Russian Federation)
|   |
Exacerbations in non- cystic fibrosis bronchiectasis (NCFB): is there a difference between self-reported events and those defined by the criteria in the literature? M. Corso Pereira (Campinas, Brazil), J. de Campos Medeiros (Campinas, Brazil), À. Cristina Da Silva (Campinas, Brazil)
|   |
Analysis of the daily symptom profile of patients with non-cystic fibrosis bronchiectasis (NCFB) using a symptom diary. M. Corso Pereira (Campinas, Brazil), J. de Campos Medeiros (Campinas, Brazil), Á. Cristina Da Silva (Campinas, Brazil)
|   |
Assessment of health-related quality of life in patients with bronchiectasis colonized by Pseudomonas aeruginosa L. Bueno Freire (Barcelona, Spain), V. Alcaraz Serrano (Barcelona, Spain), L. Fernández Barat (Barcelona, Spain), G. Scioscia (Foggia, Italy), P. Oscanoa (Barcelona, Spain), N. Vázquez (Barcelona, Spain), A. López Gavin (Barcelona, Spain), A. Gabarrús (Barcelona, Spain), R. Amaro (Barcelona, Spain), A. Ceccato (Barcelona, Spain), R. López Aladid (Barcelona, Spain), A. Torres (Barcelona, Spain)
|   |
Risk stratifying pleural infection using RAPID score in an Asian population C. Wong (Hong Kong, Hong Kong), L. So (Hong Kong, Hong Kong), L. Yam (Hong Kong, Hong Kong)
|   |
Identification of microbiome etiology associated with drug resistance in pleural empyema Z. Chen (Nan ning, China), H. Cheng (Shen Zhen, China), Z. Cai (Shen Zhen, China), Q. Wei (Nan ning, China), J. Li (Nan ning, China), J. Liang (Nan ning, China), W. Zhang (Nan ning, China), Z. Yu (Shen Zhen, China), D. Liu (Shen Zhen, China), L. Liu (Shen Zhen, China), Z. Zhang (Liu Zhou, China), W. Ke (Nan ning, China), L. Yang (Shen Zhen, China)
|   |
Parapneumonic pleural effusion prognosis – retrospective study in an Internal Medicine Service C. Cortesão (Coimbra, Portugal), P. Carvalho (Coimbra, Portugal), P. Silva Santos (Coimbra, Portugal), J. Pacheco (Coimbra, Portugal), A. Carvalho (Coimbra, Portugal)
|   |
Clinicoradiological profile and treatment outcome of empyema thoracis patients A. GANGULY (KOLKATA, India), S. Bhattacharya (KOLKATA, India), A. Dey (KOLKATA, India)
|   |
Rate and impact of the infection risk related to reusable flexible bronchoscopes: Systematic literature review and meta-analysis H. Travis (Ballerup, Denmark), R. Russell (Ballerup, Denmark)
|   |
Pleural empyema in hospitalization and mortality risk: application of RAPID score. I. DOMINGUEZ ZABALETA (Madrid, Spain), S. Suarez Escudero (Madrid, Spain), B. Recio Moreno (Madrid, Spain), C. Castro Riera (Madrid, Spain), Z. Ji (Madrid, Spain), J. De Miguel Diez (Madrid, Spain), L. Puente Maestu (Madrid, Spain), W. Giron Matute (Madrid, Spain)
|   |
A experience of using intrapleural fibronolytics in a large district general hospital M. Niazi (Birmingham, United Kingdom), O. Ojuawo (Birmingham, United Kingdom), A. Ali (Birmingham, United Kingdom), U. Maqsood (Birmingham, United Kingdom), A. Sahal (Birmingham, United Kingdom)
|   |